Non-selective pharmacological inhibition of TNF using etanercept (ETN; a fusion protein consisting of TNFR2 attached to Fc of IgG that target both forms of TNF) has been effective in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (26). Here, TNF is linked to rheumatoid arthritis.